Kuznetsova tested positive for a stimulant

LOUVAIN-LA-NEUVE, Belgium -- The World Anti-Doping Agency
has no plans to intervene in U.S. Open champion Svetlana
Kuznetsova's positive drug test.

The Russian tested positive for the stimulant ephedrine during
an offseason exhibition in Belgium on Dec. 19. Analysis of her
backup sample has not been done yet.

WADA president Dick Pound, in Belgium for a sports conference
Friday, faulted Belgian regional sports minister Claude Eerdekens
for announcing the result. Eerdekens said he acted in the interest
of openness.

"He should not be saying anything because there is no positive
test until we have a B," Pound told The Associated Press. "Then
we don't know whether it is an in- or out-of-competition event."

Pound said WADA would not pursue the case if tennis authorities
did not consider it a doping infraction.

The WTA Tour has suggested Kuznetsova will not be penalized.
Under anti-doping rules, ephedrine -- often found in cold medicine --
is not banned outside competition. Pound said it was up to sports
federations to set the limits on the offseason.

"It is an in-competition prohibition," Pound said. "An
exhibition match is not competition."